Sensitivity and Specificity of a Celiac Disease Clinical Test
This paper evaluates the diagnostic performance of a hypothetical clinical test for celiac disease using a sample of 200 confirmed patients and 200 controls. It calculates sensitivity (95%) and specificity (75%), explains the clinical significance of each metric, and computes the positive predictive value (PPV). The analysis then applies these values to a population of 10,000 individuals at disease prevalence rates of 1% and 5%, demonstrating how low prevalence dramatically reduces PPV — dropping to approximately 3.7% and 16.7%, respectively. The paper concludes that a test with high sensitivity but only moderate specificity is insufficient as a standalone diagnostic tool when prevalence is low, and recommends pairing it with a high-specificity test or dietary confirmation.
- Introduction to the Celiac Disease Clinical Test: Test setup, sample, and raw result counts
- Calculating Sensitivity and Specificity: Step-by-step formulas yield 95% and 75%
- Clinical Implications of Sensitivity and Specificity: When high sensitivity matters and its limits
- Positive Predictive Value: PPV formula applied to test data
- Effect of Disease Prevalence on Predictive Value: PPV collapses at 1% and 5% prevalence
- Conclusion: Low specificity requires a confirmatory test
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Grounds every formula in a concrete numerical example, making abstract statistical concepts immediately accessible.
- Moves logically from test-level metrics (sensitivity, specificity) to population-level implications (PPV at varying prevalence), showing real-world diagnostic consequences.
- Contextualizes findings clinically — noting that celiac disease's low-harm treatment changes the threshold for acceptable test performance.
Key academic technique demonstrated
The paper exemplifies applied quantitative reasoning in a clinical context: it derives statistical measures from raw contingency-table data, then stress-tests those measures across different population scenarios to expose the limitations of a seemingly strong test. This "what happens when prevalence changes" approach is a standard and highly effective technique in diagnostic epidemiology.
Structure breakdown
The paper opens by defining the test scenario and reporting raw counts, then walks through sensitivity and specificity calculations step by step. A clinical interpretation section situates the numbers within treatment-risk logic. PPV is introduced and computed, followed by a table extending the analysis to two prevalence scenarios. The conclusion synthesizes the population-level findings and proposes a practical solution — pairing the test with a high-specificity confirmatory step.
Introduction to the Celiac Disease Clinical Test
The sensitivity of a clinical diagnostic test is defined by its ability to correctly identify patients who have the disease in question (Lalkhen & McCluskey, 2008). In the example provided, 200 patients confirmed to have celiac disease and 200 controls confirmed not to have the disease were used to evaluate the efficacy of a new clinical test. The results are as follows:
- True positives = 190/200 = 0.95, or 95%
- False positives = 50/200 = 0.25, or 25%
- True negatives = 150/200 = 0.75, or 75%
- False negatives = 10/200 = 0.05, or 5%
Calculating Sensitivity and Specificity
Sensitivity is determined by dividing true positives by the sum of true positives and false negatives (Lalkhen & McCluskey, 2008). In this example: 190 / (190 + 10) = 0.95, or 95%.
The specificity of a clinical test describes its ability to exclude individuals who do not have the disease — that is, to minimize false positive results (Lalkhen & McCluskey, 2008). Specificity is calculated by dividing true negatives by the sum of true negatives and false positives. In this example: 150 / (150 + 50) = 0.75, or 75%. The sensitivity and specificity for the new celiac disease test are therefore 95% and 75%, respectively, which would be considered highly sensitive and moderately specific.
Clinical Implications of Sensitivity and Specificity
As Lalkhen and McCluskey (2008) discuss, high sensitivity is important for serious diseases for which effective treatments are available. However, if false positive results put patients at risk of harm from those treatments, a second test with low sensitivity but high specificity should be used to eliminate false positives from the patient population. Celiac disease does not fall into this high-risk category, because most patients can lead a full life simply by eliminating gluten from their diets (Celiac Disease Foundation, n.d.). A diagnostic test with moderate sensitivity and specificity is therefore sufficient for this condition, and false positives can be resolved by assessing patient responsiveness to a gluten-free diet.
Positive Predictive Value
The positive predictive value (PPV) of a clinical test is useful because it provides a numerical estimate of the likelihood that a person who tests positive actually has the disease (Lalkhen & McCluskey, 2008). PPV is calculated by dividing true positives by the sum of true positives and false positives. In the example above: 190 / (190 + 50) = 0.792, or 79.2%. This is a strong PPV, as nearly 80% of individuals with the disease will test positive.
Conclusion
The high false positive rate — that is, low specificity — would preclude using this test for patients suspected of suffering from celiac disease unless it is combined with another clinical test possessing high specificity to reduce false positives, such as confirmation through dietary modification. These findings illustrate a fundamental principle in diagnostic epidemiology: a test that performs well in a high-prevalence sample can deliver misleading results when applied to a general population with low disease prevalence.
References
Celiac Disease Foundation. (n.d.). Poorly responsive celiac disease. Retrieved from
Lalkhen, A. G., & McCluskey, A. (2008). Clinical tests: Sensitivity and specificity. Continuing Education in Anaesthesia, Critical Care & Pain, 8(6), 221–223.
Create your account
Always verify citation format against your institution’s current style guide requirements.